Overview on Juvenile Idiopathic Arthritis: A Review

Hazazi, Ahlam Shary J. and Alshehri, Badaya Awadh M. and Alali, Yara Abdulrahman and Alqarni, Rahf Mohammed I. and Hazazi, Ibtisam Shary J. and Albalawi, Nujud Abdulqader and Murad, Dimah Mohammed A. Abu and Alatawi, Atheer Mansour E and Alatawi, Nouf Ali and Yousuf, Maisaa Mokhtar M. (2021) Overview on Juvenile Idiopathic Arthritis: A Review. Journal of Pharmaceutical Research International, 33 (40B). pp. 139-147. ISSN 2456-9119

[thumbnail of 3086-Article Text-4820-1-10-20221006.pdf]

Text
3086-Article Text-4820-1-10-20221006.pdf - Published Version
Download (209kB)

Official URL: https://doi.org/10.9734/jpri/2021/v33i40B32273

Abstract

Juvenile idiopathic arthritis (JIA) is a broad term that refers to a clinically heterogeneous group of arthritis that develops before the age of 16 and has no recognized cause. JIA treatment has evolved during the last two decades. Clinical trials research has been directed at more specific therapeutics based on what has been discovered about the biology of disease. Pediatric rheumatologists now have many more medications to offer patients, with the expectation that their disease will be managed, thanks to advances in immune system research and the introduction of biologic drugs in the twenty-first century. Continuing development in these biological agents and discoveries new drugs as long as developing current gene analysis techniques is the best method to treat JIA and provide best quality of life.

Item Type:	Article
Subjects:	Opene Prints > Medical Science
Depositing User:	Managing Editor
Date Deposited:	06 Mar 2023 06:22
Last Modified:	24 Apr 2024 08:58
URI:	http://geographical.go2journals.com/id/eprint/1394

Actions (login required)

: View Item